eClinical Tech News

Aquestive Therapeutics is steering its sublingual epinephrine candidate, Anaphylm, toward a potential U.S. launch in the first quarter of...

ADMA Biologics posted third-quarter 2025 revenue of $134.2 million, up 12% year over year, with GAAP net income of...

Cytek Biosciences posted third-quarter 2025 revenue of $52.3 million, up 2% year over year, and expanded its installed base...

Kymera Therapeutics has completed enrollment and dosing in its Phase 1b BROADEN study of KT-621, a first-in-class, once-daily oral...

Amneal Pharmaceuticals and Mabxience have secured FDA approvals for Boncresa (denosumab-mobz), a biosimilar to Prolia, and Oziltus (denosumab-mobz), a...

NRx Pharmaceuticals has refiled its ANDA for KETAFREE, a preservative-free ketamine injection, and reports supportive FDA correspondence pointing to...

Inotiv posted preliminary Q4 FY2025 revenue of $137.5–138.5 million and full-year FY2025 revenue of $512.5–513.5 million, alongside a Discovery...

Cosmos Health posted record third-quarter results, with revenue up 38% year over year to $17.1 million, gross profit more...

INVO Fertility reported third-quarter 2025 revenue of $1.76 million, up 23% year over year, with consolidated clinic revenue from...

Genfit reported third-quarter 2025 financials with cash and equivalents at €119.0 million and nine-month revenue of €39.2 million, driven...